Insulin intervention development for people with type 2 diabetes.

  • Research type

    Research Study

  • Full title

    A mixed methods study to support insulin self-management for people with type 2 diabetes.

  • IRAS ID

    208469

  • Contact name

    Kirsty Winkley

  • Contact email

    kirsty.1.winkley@kcl.ac.uk

  • Sponsor organisation

    King's College Hospital NHS Foundation Trust

  • Duration of Study in the UK

    4 years, 6 months, 2 days

  • Research summary

    In the UK the average duration of diabetes is 8.5 years with hyperglycaemia (HbA1c 84 mmols/mol) before insulin is first prescribed, suggesting a significant delay, which is bringing forward the risk of diabetes complications. The role of specific psychological factors with regard to the delay in insulin initiation is understudied. This research will aim to i) describe patient perspectives of insulin initiation in type 2 diabetes mellitus (T2DM), and ii) use this knowledge to develop a motivational interviewing (MI) based intervention to address these issues. The study will conduct qualitative interviews of approximately 30 patients with T2DM who receive treatment in the South London borough of Lambeth. Interviews will determine barriers to insulin self-management, views on current education courses and suggestions for additional support. Information gathered from the interviews and results from an 8year follow-up of a cohort study (identifying psychological factors are associated with delay in insulin initiation) will be used in the development of a new psychological intervention. Initial testing of the intervention will take place in a purposive sample of people who have initiated insulin (from Lambeth) with the aim of recruiting 6-10 people who will receive it. Exit interviews will be used to determine acceptability of the intervention. Finally, 60 patients will be recruited to test a newly developed group MI intervention as an adjunct to insulin start for people with T2DM in a feasibility randomised controlled trial (RCT). It will determine whether it is acceptable and appropriate for patients and whether the trial can be successfully delivered within primary care.

  • REC name

    London - South East Research Ethics Committee

  • REC reference

    17/LO/0363

  • Date of REC Opinion

    18 Apr 2017

  • REC opinion

    Further Information Favourable Opinion